PRMT5 and cancer: In summary, PRMT5 is a key regulator of RNA splicing [55], and as an effector molecule for SDMA marks deposited by PRMT5, it is not surprising that SND1 is also integral to the maintenance of normal splicing programs that can go awry in a cancer setting.